The report provides a detailed analysis essential for establishing an Uracil Mustard production plant. It encompasses all critical aspects necessary for Uracil Mustard production, including the cost of Uracil Mustard production, Uracil Mustard plant cost, Uracil Mustard production costs, and the overall Uracil Mustard production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Uracil Mustard production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Uracil mustard is a nitrogen mustard alkylating agent used as an anticancer chemotherapy drug. It works by cross-linking DNA, binding to guanine and cytosine bases, which stops DNA synthesis and function. This mechanism causes cytotoxicity and apoptosis, making it effective against lymphatic malignancies and other cancers. It is utilised in chemotherapy for cancers, mainly lymphomas and leukaemia. It has an alkylating nature that can cause side effects such as gastrointestinal and bone marrow toxicity. It finds its usage in medicinal chemistry as a targeted cancer treatment agent with nitrogen mustard pharmacophores linked to nucleobase frames.
The market for uracil mustard is driven by the rising cases of cancer and the increasing demand for effective chemotherapeutic agents. Its usage for treating lymphatic malignancies, leukaemias, and certain solid tumours, alongside advancements in targeted cancer therapies, boosts its demand. The expanding pharmaceutical and biotechnology sectors, increased healthcare expenditures, and growing oncology research investments also contribute to its market growth.
The regulatory constraints and strict quality standards for pharmaceutical ingredients, complexity in synthesis involving hazardous intermediates like nitrogen mustards, affect industrial uracil mustard procurement. The market is also impacted by regional healthcare infrastructure, approvals of new formulations, and competition from other alkylating agents and emerging cancer therapies.
Raw Material for Uracil Mustard Production
According to the Uracil Mustard production plant project report, the key raw materials used in the production of Uracil Mustard include 5-Aminouracil-Ethylene Oxide-Glacial Acetic Acid-Thionyl Chloride.
Production Process of Uracil Mustard
The extensive Uracil Mustard production cost report consists of the following major industrial production process:
- From 5-Aminouracil: The production process of Uracil Mustard involves a two-step chemical process. First, 5-aminouracil is reacted with ethylene oxide to form 5-bis(2-hydroxyethyl)aminouracil. This reaction takes place in the presence of water and an acidic catalyst like glacial acetic acid. This intermediate is treated with thionyl chloride, which converts the hydroxyethyl groups into chloroethyl groups that lead to the formation of uracil mustard. This product is separated and purified to get Uracil Mustard as the final product.
Uracil mustard is a creamy to off-white, odourless crystalline solid. It has a molecular formula of C8H11Cl2N3O2 and a molecular weight of 252.1 g/mol. It has a melting point of around 206 degree Celsius and a density of around 1.635 g/cm³. The refractive index is about 1.610. It is sparingly soluble in DMSO and slightly soluble in heated methanol, with negligible solubility in water. The compound appears as crystals from aqueous methanol solutions and has a predicted pKa of 9.42 ± 0.10. It is non-combustible but decomposes upon heating to produce corrosive and toxic fumes. It reacts as a base and is toxic, with inhalation, ingestion, or skin contact causing severe injury or death.